We are live on ! Find out more
PALI icon

Palisade Bio
PALI

16 hedge funds and large institutions have $10.1M invested in Palisade Bio in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

606% more capital invested

Capital invested by funds: $1.43M → $10.1M (+$8.69M)

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

60% more funds holding

Funds holding: 10 → 16 (+6)

0.04% more ownership

Funds ownership: 0% → 0.04% (+0.04%)

Holders
16
Holders Change
+6
Holders Change %
+60%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
5
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
Altium Capital Management
New York
+$11M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.07M
3
Renaissance Technologies
Renaissance Technologies
New York
+$880K
4
SWIG
Strategic Wealth Investment Group
Kentucky
+$322K
5
SM
Sabby Management
Florida
+$318K

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$75K
2
Northern Trust
Northern Trust
Illinois
-$31K
3
VF
Virtu Financial
New York
-$27.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
Altium Capital Management
New York
$7.43M +$11M +2,433 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$968K +$1.07M +236 +291%
Renaissance Technologies
3
Renaissance Technologies
New York
$591K +$880K +194 New
SWIG
4
Strategic Wealth Investment Group
Kentucky
$216K +$322K +71 New
SM
5
Sabby Management
Florida
$214K +$318K +70 New
State Street
6
State Street
Massachusetts
$115K +$172K +38 New
BlackRock
7
BlackRock
New York
$101K +$145K +32 +3,200%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$100K +$27.2K +6 +22%
UBS Group
9
UBS Group
Switzerland
$90K +$118K +26 +650%
PAG
10
Private Advisor Group
New Jersey
$86K +$127K +28 New
VF
11
Virtu Financial
New York
$74K -$27.2K -6 -20%
HighTower Advisors
12
HighTower Advisors
Illinois
$68K – – –
Citadel Advisors
13
Citadel Advisors
Florida
$42K +$36.3K +8 +133%
Morgan Stanley
14
Morgan Stanley
New York
$16K +$22.7K +5 New
EWM
15
Evermay Wealth Management
Virginia
$7K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$4K +$4.54K +1 New
Wells Fargo
17
Wells Fargo
California
$1K – – –
Bank of New York Mellon
18
Bank of New York Mellon
New York
– -$75K -10 Closed
Northern Trust
19
Northern Trust
Illinois
– -$31K -4 Closed

PALI Hedge Fund Activity: Q2 2021 in Review

16 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2021, worth a combined $10.1M — up 606% from $1.43M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new PALI positions and 2 closed out — a net gain of 6 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Altium Capital Management, opening a new position worth an estimated $11M. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $75K sold.

  • 16 institutional investors held Palisade Bio (PALI) as of Q2 2021, up from 10 in Q1 2021.
  • Funds reported $10.1M of Palisade Bio stock for Q2 2021, up 606% quarter-over-quarter.
  • 8 funds opened new Palisade Bio positions in Q2 2021 and 2 closed out, a net change of +6 holders.
  • The largest Palisade Bio buyer in Q2 2021 was Altium Capital Management, an estimated $11M added.
  • The largest Palisade Bio seller in Q2 2021 was Bank of New York Mellon, an estimated $75K sold.

Based on aggregated 13F filings for Q2 2021.